Unique ID issued by UMIN | UMIN000037532 |
---|---|
Receipt number | R000042788 |
Scientific Title | Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer. |
Date of disclosure of the study information | 2019/08/01 |
Last modified on | 2022/08/01 13:19:12 |
Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.
Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.
Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.
Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.
Japan |
Colorectal Cancer
Gastrointestinal surgery |
Malignancy
NO
To pick up high risk cases of Stage II colorectal cancer using lymph nodes metastasis detected by OSNA and to clarify the necessity of postoperative chemotherapy.
Efficacy
3 year recurrence free survival rate
5 year recurrence free survival rate
Association between clinicopathological factors and diagnosis of OSNA
Association with postoperative adjuvant chemotherapy
Observational
20 | years-old | <= |
79 | years-old | >= |
Male and Female
<OSNA installed facility>
Patients 20 years old or older
Patients diagnosed with cStage I-III colorectal cancer
Patients who is to carry out OSNA
Patients who have not offered a refuse to optout
<OSNA non-installed facility>
Patients 20 years old or older
Patients diagnosed with cStage I-III colorectal cancer
Lymph nodes collected at the time of surgery is cryopreserved and available
Patients who obtained written consent
<OSNA installed facility>
Patients who lack the ability to agree
Patients who receive neoadjuvant chemotherapy
Active double cancer (synchronous double cancer/Multiple cancer and metachronous double cancer/multiple cancer with disease-free survival of 5 years or less, but excluding carcinoma in situ that is judged to be cured by local treatment
Patients who died or relapsed within 60 days after the operation
Patients who is judged to be ineligible to participate in the study by the research principal doctor or co-investigator
<OSNA non-installed facility>
Patients who lack the ability to agree
Patients who receive neoadjuvant chemotherapy
Active double cancer (synchronous double cancer/Multiple cancer and metachronous double cancer/multiple cancer with disease-free survival of 5 years or less, but excluding carcinoma in situ that is judged to be cured by local treatment
Patients who died or relapsed within 60 days after the operation
Patients who is judged to be ineligible to participate in the study by the research principal doctor or co-investigator
3000
1st name | Nariaki |
Middle name | |
Last name | Matsuura |
Osaka International Cancer Institute
Gastroenterological surgery
5418567
3-1-69 Otemae, Chuoku, Osaka
0669451181
nmatsuura@mc.pref.osaka.jp
1st name | Mamoru |
Middle name | |
Last name | Uemura |
Osaka University
Department of Gastroenterology
5650871
2-2 Yamadaoka, Suita, Osaka
0668793251
muemura@gesurg.med.osaka-u.ac.jp
Osaka International Institute
BTC Research
Self funding
Osaka University Clinical Research Review Committee
2-2 Yamadaoka, Suita, Osaka
0662108289
rinri@hp-crc.med.osaka-u.ac.jp
NO
2019 | Year | 08 | Month | 01 | Day |
Unpublished
Open public recruiting
2019 | Year | 05 | Month | 13 | Day |
2019 | Year | 05 | Month | 14 | Day |
2019 | Year | 05 | Month | 14 | Day |
2023 | Year | 06 | Month | 30 | Day |
2026 | Year | 06 | Month | 30 | Day |
none
2019 | Year | 07 | Month | 29 | Day |
2022 | Year | 08 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042788